ImmunoGen, Inc. (NASDAQ:IMGN) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to ImmunoGen's Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Today's conference is being recorded.

Related Keywords

United Kingdom ,Mark Enyedy ,Canaccord Genuity ,Todd Talarico ,John Newman ,Anna Berkenblit ,Anabel Chan ,Etzer Darout ,Oxford Biotherapeutics ,Renee Lentini ,Michael Vasconcelles ,Michael Schmidt ,Nasdaq ,Immunogen Inc ,Call Transcript March ,Fourth Quarter ,Full Year ,Operating Results Conference ,Chief Medical Officer ,Medical Affairs ,Interim Chief Commercial Officer ,Risk Factors ,Executive Vice President ,Daniel Char ,With Highest Medical Research Spending ,Clinical Oncology ,Growth United Kingdom Stocks ,Growth Saas Stocks ,